Investigation of New Delhi metallo-beta-lactamase-1 (blaNDM-1) gene in carbapenemresistant Enterobacterales strains isolated from a university hospital in Turkey

Investigation of New Delhi metallo-beta-lactamase-1 (blaNDM-1) gene in carbapenemresistant Enterobacterales strains isolated from a university hospital in Turkey

In this study, the presence of blaNDM-1 gene in carbapenem-resistant Enterobacterales obtained from various clinical specimen of a University Hospital in Turkey between the years 2014-2019, has been investigated. Carbapenem-resistant Enterobacterales were identified using Vitek 2. The presence of Metallo beta lactamase in these bacteria was investigated by phenotypically modified hodge test and genotypically by PCR. Of the 110 carbapenem-resistant Enterobacterales isolates, six (5.5%), 17 (15.5%) and 87 (79.0%) were identified as E. cloacae, E. coli and K. pneumoniae , respectively. While blaNDM-1gene was found in 35 (31.8%) K. pneumoniae and three (2.7%) E. coli strains, all 38 strains were found positive for blaNDM-1gene by the modified hodge test. It was determined that six E. cloacae strains did not contain the blaNDM-1 gene. Multiple antibiotic resistances were detected in carbapenem-resistant Enterobacterales strains positive for blaNDM-1. However, 29 K. pneumoniae and two E. coli strains were identified as resistant to tigecycline. Turkey also risks of the world along with other resistance enzymes and bacteria NDM-1 producing the rates must be determined globally and periodically. The fast spread of such resistant through transferable ways should not be overlooked, because enzymatic resistance genes can lead to high mortality hospital outbreaks worldwide.

___

  • Bush K. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacterales. Curr Opin Microbiol. 2010;13:558-64.
  • Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infec Dis. 2016;3:15-21.
  • Kandeel A. Epidemiology of carbapenemase producing Enterobacterales in a general hospital. J Microbiol Infec Dis. 2015;5:57-62.
  • Ye Y, Xu L, Han Y, et al. Mechanism for carbapenem resistance of clinical Enterobacterales isolates. Exp Ther Med. 2018;15:1143-9.
  • Lim CL, Spelman D. Mortality impact of empirical antimicrobial therapy in ESBL and AmpC producing Enterobacterales bacteremia in an Australian tertiary hospital. Infec Dis Health. 2019;24:124-33.
  • Beware, centers for disease control and prevention report (cdc). department of health and human services. 2015;02.04.21
  • Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, et al. Treatment of infections caused by extended spectrum beta lactamase, AmpC, and carbapenemase producing Enterobacterales. Clin Microbiol Reviews. 2018;31:2.
  • Suay-García B, Pérez-Gracia MT. Present and Future of CarbapenemResistant Enterobacterales (CRE) Infections. Antibiotics. 2019;8:122.
  • Yong D, Toleman MA, Giske CG, et al. Characterization of a new metalloβ-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 2009;53:5046-54.
  • Karabay O, Altindis M, Koroglu M, et al. The carbapenem-resistant Enterobacterales threat is growing: NDM-1 epidemic at a training hospital in Turkey. Ann Clin Microbiol Antimicrob. 2016;15:6.
  • Berçot B, Poirel L, Dortet L, et al. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacterales. J Antimicrob Chemother. 2011;66:2295-7.
  • Jin Y, Shao C, Li J, et al. Outbreak of multidrug resistant NDM-1-producing Klebsiella pneumoniae from a neonatal unit in Shandong Province, China. PloS One. 2015;10:0119571.
  • Binod GC, Nim RS, Binod R, et al. Detection of blaNDM-1gene among the carbapenem resistant Escherichia coli and Klebsiella pneumoniae isolates from a children’s hospital in Nepal. Novel Res Microbiol J. 2018;2:65-74.
  • Yoon EJ, Kang DY, Yang JW, et al. New Delhi Metallo-Beta-LactamaseProducing Enterobacterales in South Korea Between 2010 and 2015. Front. Microbiol. 2018;9:571.
  • Xiang T, Chen C, Wen J, et al. Resistance of Klebsiella pneumoniae Strains Carrying blaNDM-1Gene and the Genetic Environment of blaNDM-1. Front Microbiol. 2020;11:700.
  • Poirel L, Ozdamar M, Ocampo-Sosa AA, et al. NDM-1-producing Klebsiella pneumoniae now in Turkey. Antimicrob Agents Chemother. 2012;56:2784-5.
  • Alp E, Perçin D, Çolakoğlu S, et al. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae in a tertiary university hospital in Turkey. J Hospital Infec. 2013;84:178-80.
  • Davarci I, Senbayrak S, Aksaray S, et al. Molecular Epidemiology of Carbapenem resistant Klebsiella pneumoniae Isolates. Anatolian Clinic J Med Sci. 2019;24:1-7.
  • Beware: European Committee on Antimicrobial Susceptibility Testing (EUCAST). Eur Society Clin Microbiol Infect Dis. 2015;02:04.21
  • Kaase M, Szabados F, Wassill L, et al. Detection of carbapenemases in Enterobacterales by a Commercial Multiplex PCR. J Clin Microbiol. 2012;50:3315-9.
  • Wang JT, Wu UI, Lauderdale TLY, et al. Carbapenem nonsusceptible Enterobacterales in Taiwan. PLoS ONE. 2015;10:e0121668.
  • Zaidah AR, Mohammad NI, Suraiya S, et al. High burden of Carbapenemresistant Enterobacterales (CRE) fecal carriage at a teaching hospital: costeffectiveness of screening in low-resource setting. Antimicrob Resist Infect Control. 2017;6:42.
  • Pollett S, Miller S, Hindler J, et al. Phenotypic and molecular characteristics of carbapenem-resistant Enterobacterales in a health care system in Los Angeles, California, from 2011 to 2013. J Clin Microbiol. 2014;52:4003-9.
  • Hammoudi D, Moubareck CA, Aires J, et al. Countrywide spread of OXA48 carbapenemase in Lebanon: surveillance and genetic characterization of carbapenem-non- susceptible Enterobacterales in 10 hospitals over a oneyear period. Int Infec Dis. 2014;29:39-44
  • Baran I, Aksu N. Phenotypic and genotypic characteristics of carbapenemresistant Enterobacterales in a tertiary-level reference hospital in Turkey. Ann Clin Microbiol Antimicrob. 2016;15:20.
  • Sahin K, Tekin A, Ozdas S, et al. Evaluation of carbapenem resistance using phenotypic and genotypic techniques in Enterobacterales isolates. Ann Clin Microbiol Antimicrob. 2015;14:44.
  • Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10:597-602.
  • Bushnell G, Mitrani Gold F, Mundy LM. Emergence of New Delhi metalloβ-lactamase type 1-producing Enterobacterales and non-Enterobacterales: global case detection and bacterial surveillance. Int J Infec Dis. 2013;17:325- 33.
  • Yanık K, Emir D, Eroğlu C, et al. Investigation of the Presence of New Delhi Metallo-Beta-Lactamase-1 (NDM-1) by PCR in CarbapenemResistant Gram-Negative Isolates. Mikrobiyol Bul. 2013;47:382-4.
  • Doyle D, Peirano G, Lascols C, et al. Laboratory detection of Enterobacterales that produce carbapenemases. J Clin Microbiol. 2012;50:3877-80.
  • Rasheed JK, Kitchel B, Zhu W, et al. New Delhi metallo-β-lactamaseproducing Enterobacterales, United States. Emerging Infec Dis. 2013;19:870-8.
  • Göttig S, Riedel-Christ S, Saleh A, et al. Impact of blaNDM-1 on fitness and pathogenicity of Escherichia coli and Klebsiella pneumoniae . Int Journal of Antimicrobial Agents. 2016;47:430-5.
  • Fazeli H, Norouzi Barough M, Ahadi AM, et al. Detection of New Delhi Metallo-Beta-Lactamase-1 (NDM-1) in carbapenem-resistant Klebsiella pneumoniae isolated from a university hospital in Iran. Hippokratia. 2015;19:205-9.
  • Hamzan NI, Yean CY, Rahman RA, et al. Detection of blaIMP4 and blaNDM1 harboring Klebsiella pneumoniae isolates in a university hospital in Malaysia. Emerg Health Threats J. 2015;8:26011.
  • Sidjabat H, Nimmo G.R, Walsh TR, et al. Carbapenem Resistance in Klebsiella pneumoniae Due to the New Delhi Metallo-β-lactamase. Clin Infec Dis. 2011;52:481-4.
  • Shahcheraghi F, Nobari S, Ghezelgeh FR, et al. First Report of New Delhi Metallo-Beta-Lactamase-1-Producing Klebsiella pneumoniae in Iran. Microbial Drug Resis. 2013;19:30-6.
Medicine Science-Cover
  • ISSN: 2147-0634
  • Yayın Aralığı: 4
  • Başlangıç: 2012
  • Yayıncı: Effect Publishing Agency ( EPA )
Sayıdaki Diğer Makaleler

Clinical and radiological outcomes of patients on whom posterior C1-C2 stabilization is applied in C2 odontoid fractures

Ramazan Pasahan, Emek Guldogan

Clinical findings and immunophenotypic profile of plasma cell leukemia: a retrospective study in a comprehensive cancer center in Turkey

Semih Basci, Fevzi Altuntas, Mehmet Sinan Dal, Fatma Meric Yilmaz, Mehmet Bakirtas, Nurgul Ozcan, Eda Ozcan, Merih Kizil Cakar

Evaluation of poisoning cases admitted to pediatric emergency department

Turgay Bork, Aslihan Kara

Investigating CFTR gene variations in patient groups with positive newborn screening test results and preliminary clinical diagnosis of cystic fibrosis in the eastern anatolia region of Turkey

Ayberk TÜRKYILMAZ, Oğuzhan YARAL

Efficacy and safety of intravenous ferric carboxymaltose in iron deficiency anemia; Real-life data from Turkey, a single center experience

Ali Eser, Nang Hseng Kyio

The role of serum tenascin-c and procalcitonin in predicting the severity of acute pancreatitis

Yavuz Beyazit, Ece Unal Cetin, Fatih Kamis, Adil Ugur Cetin, Mehmet Arslan

Effects of the elixhauser comorbidity index on the time of discharge and30-day mortality rate in geriatric and non-geriatric patientsundergoing partial hip prosthesis arthroplasty

Ozkan Gorgulu, Sadullah Turhan

Have problems been experienced in the treatment of eye patients during the COVID-19 pandemic?

Abdulgani Kaymaz, Adem Soydan

Nursing students' perspectives on the quality of nursing care in-home health care

Elif DONMEZ, İLKNUR DOLU, Ahu KÜRKLÜ

Early onset androgenic alopecia as the male phenotypic equivalent of polycystic ovarian syndrome is associated in high oxidative stress

Didem Dereli Akdeniz1, Ibrahim Omeroglu